Skip to main content
CNTA logo

CNTA · Centessa Pharmaceuticals plc

$40.50 +0.00 (+0.00%) At close · Jun 29
Market Cap
$6.27B
Shares
154.73M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Saurabh Saha $11,877,244
Stephen Kanes $6,812,680
John Crowley $3,842,835
Fiscal 2024
Executive Total
Saurabh Saha $5,563,120
John Crowley $4,120,748
Iqbal Hussain $2,046,325
Fiscal 2023
Executive Total
Saurabh Saha $2,705,874
Antoine Yver $1,380,739
David Grainger $1,363,599
David Chao $1,317,905
Iqbal Hussain $1,181,713
John Crowley
Fiscal 2022
Executive Total
Saurabh Saha $9,612,230
Gregory Weinhoff $3,309,069
David Chao $3,309,069
Antoine Yver $2,517,232
David Grainger $2,447,805
Fiscal 2021
Executive Total
Antoine Yver $17,127,519
Saurabh Saha $16,068,587
Gregory Weinhoff $4,043,608
David Chao $3,962,067
Fiscal 2020
Executive Total
Saurabh Saha
Gregory Weinhoff
Antoine Yver
Key facts CIK 1847903 CUSIP 152309100 13F (30d) 2 filings 2 filers Visit website Investor relations